Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women With HR+, HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 1b Dose Escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women With HR+, HER2− Advanced Breast Cancer
Clin. Cancer Res 2020 Sep 30;[EPub Ahead of Print], A Bardia, S Modi, M Oliveira, J Cortés, M Campone, BBY Ma, LY Dirix, A Weise, B Hewes, I Diaz-Padilla, Y Han, P Deshpande, T Samant, CK Rodriguez Lorenc, W He, F Su, M Chavez-MacGregorFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.